Bart joined NLO in 2000. Previously, he headed the IP department of the Pharming Group in Leiden (Netherlands) and worked as a European patent attorney at DSM/Gist-brocades in Delft (Netherlands). Bart also worked as a molecular biologist in both academic and industrial research settings at Gist-brocades, the University of California at San Diego (U.S.) and the Netherlands Cancer Institute.
Bart works in all areas of biotechnology, especially molecular biology, genomics, biochemistry, bioinformatics, immunology, microbiology, transgenic animals, classical and molecular plant genetics. He has extensive experience in drafting and prosecuting complex patent applications and frequently advises biotech firms on their IP strategy.
Bart has an MSc in (Bio)Chemistry (cum laude, 1985) and a PhD in Molecular Biology under Professor Piet Borst, from Amsterdam University.
Bart is a member of the Biotech Committee of the Institute of Professional Representatives before the European Patent Office (EPI), a member of Association Internationale pour la Protection de la Propriété Intellectuelle (AIPPI) and the American Intellectual Property Law Association (AIPLA).
Bart was involved in opposition/appeal proceedings on BRCA1 (T1213/05 and T666/05), at Edinburgh's University stem cell patent (T1079/03), cross-border litigation on HerceptinTM (Roche/Genentech vs Chiron) and on lipases (Novozymes vs DSM) and in several due diligence evaluations on the IP assets of biotech firms.
On a regular basis we are looking for people to join our company. Are you interested in a career at NLO? Please visit our special working at NLO website.
Intellectual Property is a valuable asset. From start-up to market leader, applying a smart strategy for patents, trademarks and/or designs adds value to every company. Examples of such successful IP strategies can be found at our page ‘Cases’. Read more